Tranexamic acid use in a patient with sickle cell disease undergoing posterior scoliosis correction surgery: safely mitigating bleeding and vaso-occlusive crises
Open Access
- 1 January 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2021 (1) , rjaa559
Abstract
A 15-year-old female with 2-year post-menarchal adolescent idiopathic scoliosis and sickle cell disease (SCD) underwent posterior scoliosis correction surgery. SCD is associated with higher rates of surgical complications, and these patients require careful management to prevent vaso-occlusive sickle cell crises (VOSCC); scoliosis correction surgery can be associated with high morbidity and mortality, including significant blood loss. Multiple techniques were employed to successfully prevent VOSCC in this patient including a preoperative transfusion, meticulous haemostasis at osteotomy sites, not performing a costoplasty despite presence of a rib hump, maintenance of intraoperative mean arterial pressure below 70 mmHg, aggressive postoperative hydration and the use of intraoperative tranexamic acid (TXA). This is the first reported case of the use of TXA in a patient with SCD and scoliosis correction surgery. A satisfactory correction was achieved with a longer than average inpatient stay due to non-sickle cell pain and protracted wound ooze.Keywords
This publication has 9 references indexed in Scilit:
- Impact of Sickle Cell Anemia on Inpatient Morbidity After Spinal FusionClinical Spine Surgery, 2019
- Tranexamic acid administration is associated with an increased risk of posttraumatic venous thromboembolismJournal of Trauma and Acute Care Surgery, 2019
- Systemic and Topical Use of Tranexamic Acid in Spinal Surgery: A Systematic ReviewGlobal Spine Journal, 2015
- Is tranexamic acid effective and safe in spinal surgery? A meta-analysis of randomized controlled trialsEuropean Spine Journal, 2013
- The biomechanics of pedicle screw-based instrumentationThe Journal of Bone and Joint Surgery. British volume, 2010
- Oral tranexamic acid as a novel treatment option for persistent haematuria in patients with sickle cell diseaseAnnals of Hematology, 2010
- Correlates of the Peak Height Velocity in Girls With Idiopathic ScoliosisSpine, 2006
- Bone involvement in sickle cell diseaseBritish Journal of Haematology, 2005
- Epileptic Seizures Following Cortical Application of Fibrin Sealants Containing Tranexamic Acid in RatsActa Neurochirurgica, 2002